XSHE300451
Market cap859mUSD
Jan 10, Last price
4.08CNY
1D
-4.00%
1Q
-14.82%
Jan 2017
-35.32%
IPO
228.48%
Name
B-SOFT Co Ltd
Chart & Performance
Profile
B-SOFT Co.,Ltd. operates in the medical and health industry in China. The company offers solutions for hospital integrated clinical management, hospital integrated medical workers and medical technicians, mobile intelligent curing and nursing, hospital sharing interconnection, intelligent clinical management decision, intelligent comprehensive management decision, and intelligent data display; and full process interconnection outside the hospital, internet plus convenience for medical treatment, internet + hospital cloud platform, internet + multidisciplinary telemedicine, and cloud platform for collaborative treatment of emergency and critical illness. It also provides intelligent health solutions comprising smart medical healthcare, national health information interconnection, classification and treatment grading clinics services, intelligent family doctor cloud, intelligent women and children cloud, intelligent management of medical big data, emergency information system, and regional health emergency command and decision-making platform solutions; and medical alliance solutions for medical alliance information construction and overall framework, hierarchical diagnosis and treatment scenarios, telemedicine scenario, collaborative diagnosis and treatment scenario, online service scenario, and integrated management scenario. In addition, the company offers intelligent interconnection, intelligent IoT, technology, and professional work solutions. B-SOFT Co.,Ltd. was founded in 1997 and is based in Hangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,615,873 5.81% | 1,527,139 -19.58% | |||||||
Cost of revenue | 1,234,390 | 1,166,399 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 381,483 | 360,740 | |||||||
NOPBT Margin | 23.61% | 23.62% | |||||||
Operating Taxes | (319) | 14,159 | |||||||
Tax Rate | 3.93% | ||||||||
NOPAT | 381,802 | 346,580 | |||||||
Net income | 36,688 -13.93% | 42,627 -89.68% | |||||||
Dividends | (15,468) | (46,494) | |||||||
Dividend yield | 0.13% | 0.41% | |||||||
Proceeds from repurchase of equity | (31,859) | (1,606) | |||||||
BB yield | 0.27% | 0.01% | |||||||
Debt | |||||||||
Debt current | 7,307 | 104,140 | |||||||
Long-term debt | 17,685 | 5,689 | |||||||
Deferred revenue | 4,905 | ||||||||
Other long-term liabilities | 4,849 | 2 | |||||||
Net debt | (1,362,176) | (1,727,817) | |||||||
Cash flow | |||||||||
Cash from operating activities | 157,842 | 144,874 | |||||||
CAPEX | (391,836) | ||||||||
Cash from investing activities | (391,662) | ||||||||
Cash from financing activities | (156,350) | 18,332 | |||||||
FCF | (80,391) | 210,180 | |||||||
Balance | |||||||||
Cash | 1,114,429 | 1,478,028 | |||||||
Long term investments | 272,740 | 359,618 | |||||||
Excess cash | 1,306,375 | 1,761,289 | |||||||
Stockholders' equity | 3,009,218 | 3,101,895 | |||||||
Invested Capital | 3,378,508 | 2,826,327 | |||||||
ROIC | 12.31% | 12.95% | |||||||
ROCE | 8.14% | 7.86% | |||||||
EV | |||||||||
Common stock shares outstanding | 1,834,425 | 1,421,266 | |||||||
Price | 6.55 -17.19% | 7.91 -29.25% | |||||||
Market cap | 12,015,484 6.88% | 11,242,212 -34.84% | |||||||
EV | 10,711,211 | 9,522,522 | |||||||
EBITDA | 498,072 | 444,432 | |||||||
EV/EBITDA | 21.51 | 21.43 | |||||||
Interest | 1,718 | 3,197 | |||||||
Interest/NOPBT | 0.45% | 0.89% |